Mainstay Capital Management LLC Amgen Inc Transaction History

Mainstay Capital Management LLC

$546 Million
Q3 2024

A detailed history of Mainstay Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Mainstay Capital Management LLC holds 4,809 shares of AMGN stock, worth $1.27 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,809

Previous 4,808 0.02%

Holding current value

$1.27 Million

Previous $1.5 Million 3.13%

% of portfolio

0.28%

Previous 0.29%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$309.38 - $337.38 $309 - $337	1 Added 0.02%	4,809 $1.55 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $28,114 - $34,166	107 Added 2.28%	4,808 $1.5 Million
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $35,490 - $42,841	-132 Reduced 2.73%	4,701 $1.34 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $251,608 - $283,844	984 Added 25.57%	4,833 $1.39 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $841,583 - $1.04 Million	3,849 New	3,849 $1.03 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $89,200 - $104,125	-500 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 16.67%	500 $104,000
Q2 2018 Aug 24, 2018	SELL	$166.05 - $186.51 $3.05 Million - $3.42 Million	-18,359 Reduced 96.84%	600 $111,000
Q2 2018 Aug 23, 2018	BUY	$166.05 - $186.51 $3.15 Million - $3.54 Million	18,959 New	18,959 $192,000
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $847 - $990	-5 Closed	0 $0
Q4 2017 Mar 28, 2018	BUY	$168.79 - $188.59 $843 - $942	5	5 $1,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mainstay Capital Management LLC with notifications on news.

Account

Mainstay Capital Management LLC Amgen Inc Transaction History